Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET
Go back to Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET| (NASDAQ: LTRN) | Delayed: 3.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.88 | 52 Week High | $ | |||
| Open | $3.88 | 52 Week Low | $ | |||
| Day High | $3.88 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $ | |||
| Volume | 114 | |||||

